Date: 2011-01-04
Type of information: Development agreement
Compound:
Company: Argenta (Galapagos subsidiary – UK Belgium) Dr. Reddy's Laboratories (India)
Therapeutic area: CNS diseases - Inflammatory diseases
Type agreement: development
commercialisation
Action mechanism:
Disease: pain-inflammation
Details: Argenta, a service division of Galapagos, has entered into a drug discovery collaboration with Dr. Reddy's Laboratories Ltd. in the area of pain and inflammation. Argenta will apply its integrated drug discovery platform and expertise for hit-to-lead and lead optimization on multiple Dr. Reddy's discovery targets in pain and inflammation.
Financial terms: Financial details were not disclosed.
Latest news:
